Skip to main content
. Author manuscript; available in PMC: 2012 Oct 19.
Published in final edited form as: Vaccine. 2011 Aug 18;29(45):8147–8155. doi: 10.1016/j.vaccine.2011.08.027

Figure 2. STF2.HA1-2 vaccine is more effective in protecting from subsequent influenza viral infection in young mice than in aged mice.

Figure 2

A-B: At either 0.3 or 3μg dose of vaccine, young mice exhibited a significantly improved survival vs. aged vaccinated mice. Differences in each plot were significant (p<0.01, Logrank). N = 20 mice / group.

C: Aged and young mice were treated with PBS control in place of STF2.HA1-2 vaccine and were then challenged with influenza virus two weeks after control boost. Survival was recorded. There was no significant difference between the groups. N = 20 / group

The raw data from this Figure is the same as shown in Figures 1A and B.